Related Experiment Video

Updated: Aug 17, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

[Emergence of type 2 diabetes in French children]

Paul Czernichow1, Nadia Tubiana-Rufi

  • 1Hôpital Robert Debré, Service d'Endocrinologie, 48 boulevard Sérurier 75019 Paris.

Bulletin De L'Academie Nationale De Medecine
|May 28, 2005
PubMed

Insights

Type 2 diabetes in children is emerging in France, though still less common than in the US. Rising childhood obesity may increase its incidence, mirroring North American trends.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Public Health

Context:

  • Diabetes mellitus (DM) heterogeneity is recognized, impacting disease management.
  • Pediatric diabetes cases require precise classification for effective treatment and research.
  • Childhood obesity is a growing concern globally, including in France.

Purpose:

  • To determine the distribution of diabetes mellitus patterns in a pediatric cohort using American Diabetes Association (ADA) criteria.
  • To document the emergence and incidence of type 2 diabetes mellitus in French children.
  • To compare pediatric type 2 diabetes mellitus trends in France over time and with international data.

Summary:

  • A review of pediatric diabetes cases (1993-1998 and 2001) in a French center used ADA criteria.
  • Type 2 diabetes mellitus was diagnosed in 8 of 370 children (1993-1998) and 5 of 90 children (2001).
  • While incidence remains low, a slight increase in pediatric type 2 diabetes mellitus was observed, often associated with significant obesity.

Impact:

  • The study highlights the low but potentially increasing incidence of type 2 diabetes mellitus in French children.
  • Findings suggest that rising childhood obesity rates in France could lead to increased type 2 diabetes mellitus cases.
  • Data provides a benchmark for monitoring pediatric diabetes trends and informing public health strategies in France.

More Related Videos

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets10:09

Leprdb Mouse Model of Type 2 Diabetes: Pancreatic Islet Isolation and Live-cell 2-Photon Imaging Of Intact Islets

Published on: May 11, 2015

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil06:48

Breakfast Habits among Schoolchildren in the City of Uruguaiana, Brazil

Published on: July 29, 2020

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...